Differential Outcomes of Early Versus Late Anti‐TNF Therapy in Ulcerative Colitis and Crohn's Disease: A Nationwide Propensity Score‐Matched Cohort Study

While early anti-TNF use was associated with differential outcomes in CD, the relationship between treatment timing and clinical course diverged in UC, challenging the assumption that early intervention is universally advantageous across IBD subtypes. These findings underscore the need for further research to identify patient subgroups that might benefit most from early intervention.

Authors

Institutions

Publication Details

Journal
United European Gastroenterology Journal
Published
2025-06-24
DOI
https://doi.org/10.1002/ueg2.70071
Citations
1
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
1.82

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Differential Outcomes of Early Versus Late Anti‐TNF Therapy in Ulcerative Colitis and Crohn's Disease: A Nationwide Propensity Score‐Matched Cohort Study

Shin Ju Oh, Sun‐Young Jung, Chi Hyuk Oh, Min‐Taek Lee et al.
1 citations
United European Gastroenterology Journal
Inflammatory Bowel Disease
1.82
article

Differential Outcomes of Early Versus Late Anti‐TNF Therapy in Ulcerative Colitis and Crohn's Disease: A Nationwide Propensity Score‐Matched Cohort Study

Shin Ju Oh, Sun‐Young Jung, Chi Hyuk Oh, Min‐Taek Lee, Chang Kyun Lee, Ji Eun Kim
article en
1 citations

Abstract

While early anti-TNF use was associated with differential outcomes in CD, the relationship between treatment timing and clinical course diverged in UC, challenging the assumption that early intervention is universally advantageous across IBD subtypes. These findings underscore the need for further research to identify patient subgroups that might benefit most from early intervention.

United European Gastroenterology JournalVol. 13(8)
Kyung Hee University (KR), Beijing Institute of Big Data Research (CN), Chung-Ang University (KR)
National Health Insurance Service, Korea Health Industry Development Institute
Openalex Percentile: Top 15%
Inflammatory Bowel Disease
1.82
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.